Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Otto

Showing results (491-500 of 558) with videos related to

Pageof 56
Sort By:
Endocrine-Related Cancer|January 21, 2017
Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytologyPablo Valderrabano, Laila Khazai, Marino E Leon, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidineLieven J Stuyver, Tamara R McBrayer, Tony Whitaker, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3'-deoxysugar analogue as potential anti-hepatitis C virus agentsPeiyuan Wang, Laurent Hollecker, Krzysztof W Pankiewicz, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 4, 2022
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancerS Sumodhee, L Guo, L Bouhlel, et al.
Thyroid : Official Journal of the American Thyroid Association|August 16, 2017
Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological ApproachPablo Valderrabano, Laila Khazai, Zachary J Thompson, et al.
Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.
The Journal of Biological Chemistry|August 31, 2010
Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977Eisuke Murakami, Tatiana Tolstykh, Haiying Bao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2012
Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?C M van der Aalst, C A van Iersel, R J van Klaveren, et al.
Bioorganic & Medicinal Chemistry|February 9, 2005
Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon systemJunxing Shi, Jinfa Du, Tianwei Ma, et al.
Journal of Medicinal Chemistry|November 13, 2004
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activityPeiyuan Wang, Laurent Hollecker, Krzysztof W Pankiewicz, et al.
Pageof 56

Showing results (491-500 of 558) with videos related to

Sort By:
Pageof 56
Endocrine-Related Cancer|January 21, 2017
Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytologyPablo Valderrabano, Laila Khazai, Marino E Leon, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidineLieven J Stuyver, Tamara R McBrayer, Tony Whitaker, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 27, 2005
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one and its 3'-deoxysugar analogue as potential anti-hepatitis C virus agentsPeiyuan Wang, Laurent Hollecker, Krzysztof W Pankiewicz, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 4, 2022
Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancerS Sumodhee, L Guo, L Bouhlel, et al.
Thyroid : Official Journal of the American Thyroid Association|August 16, 2017
Cancer Risk Stratification of Indeterminate Thyroid Nodules: A Cytological ApproachPablo Valderrabano, Laila Khazai, Zachary J Thompson, et al.
Antiviral Research|September 11, 2002
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infectionsRobert Snoeck, Graciela Andrei, Bahram Bodaghi, et al.
The Journal of Biological Chemistry|August 31, 2010
Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977Eisuke Murakami, Tatiana Tolstykh, Haiying Bao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2012
Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?C M van der Aalst, C A van Iersel, R J van Klaveren, et al.
Bioorganic & Medicinal Chemistry|February 9, 2005
Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon systemJunxing Shi, Jinfa Du, Tianwei Ma, et al.
Journal of Medicinal Chemistry|November 13, 2004
Synthesis of N3,5'-cyclo-4-(beta-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activityPeiyuan Wang, Laurent Hollecker, Krzysztof W Pankiewicz, et al.
Pageof 56